Rekombinanter MLANA Antikörper
Kurzübersicht für Rekombinanter MLANA Antikörper (ABIN7861713)
Target
Alle MLANA Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- Recombinant MART-1 / Melan-A / MLANA (Melanoma Marker) Antibody
-
Spezifität
- This antibody recognizes a protein doublet of 20-22 kDa, identified as MART-1 (Melanoma Antigen Recognized by T cells 1) or Melan-A. MART-1 is a newly identified melanocyte differentiation antigen recognized by autologous cytotoxic T lymphocytes. Seven other melanoma associated antigens recognized by autologous cytotoxic T cells include MAGE-1, MAGE-3, tyrosinase, gp100, gp75, BAGE-1, and GAGE-1. Subcellular fractionation shows that MART-1 is present in melanosomes and endoplasmic reticulum. This MAb labels melanomas and other tumors showing melanocytic differentiation. It is also a useful positive-marker for angiomyolipomas. It does not stain tumor cells of epithelial, lymphoid, glial, or mesenchymal origin.
-
Aufreinigung
- 200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.
-
Immunogen
- Recombinant full-length human MART-1 protein
-
Isotyp
- IgG1, kappa
-
-
anti-Melan A (MLANA) antibody
MLANA Reaktivität: Human, Maus, Ratte WB, IF, FACS, IHC Wirt: Maus Monoclonal M2-9E3 unconjugated
anti-Melan A (MLANA) antibodyMLANA Reaktivität: Human, Maus, Ratte WB, IHC Wirt: Kaninchen Monoclonal MLANA-1761R unconjugated Recombinant Antibody
anti-Melan A (MLANA) antibodyMLANA Reaktivität: Human, Pferd WB, IHC Wirt: Maus Monoclonal M2-7C10 unconjugated
anti-Melan A (MLANA) (AA 34-60) antibodyMLANA Reaktivität: Human WB, FACS Wirt: Kaninchen Polyclonal RB19079 unconjugated
anti-Melan A (MLANA) (AA 48-118) antibodyMLANA Reaktivität: Human WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Melan A (MLANA) (AA 1-118) antibodyMLANA Reaktivität: Human WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Melan A (MLANA) (full length) antibodyMLANA Reaktivität: Human IHC Wirt: Maus Monoclonal 901M- unconjugated Recombinant Antibody
anti-Melan A (MLANA) (AA 48-118) antibodyMLANA Reaktivität: Human ELISA Wirt: Maus Monoclonal 2F3B7 unconjugated
anti-Melan A (MLANA) antibodyMLANA Reaktivität: Human, Maus, Ratte, Hund WB, IF, FACS, IHC Wirt: Maus Monoclonal A103 unconjugated
anti-Melan A (MLANA) antibodyMLANA Reaktivität: Human, Maus, Ratte, Hund WB, IHC Wirt: Kaninchen Monoclonal MLANA-1409R unconjugated Recombinant Antibody
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 200 μg/mL
-
Buffer
- Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
-
- MLANA (Melan A (MLANA))
-
Andere Bezeichnung
- MART-1
-
Hintergrund
-
Antigen LB39-AA, Antigen SK29-AA, Melanoma antigen recognized by T-cells 1, MLAN-A, MLANA
SK-MEL-13 or SK-MEL-19 melanoma cell lines. Melanomas, COLO 38 cells
-
Molekulargewicht
- 20-22kDa (doublet)
-
Gen-ID
- 2315, 154069
-
UniProt
- Q16655
Target
-
